Novel anti-inflammatory compounds from Myrsine seguinii, terpeno-benzoic acids, are inhibitors of mammalian DNA polymerases. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Novel anti-inflammatory compounds from Myrsine seguinii, terpeno-benzoic acids, are inhibitors of mammalian DNA polymerases.

Biochim Biophys Acta. 2000 Jun 1;1475(1):1-4. Unique Identifier : AIDSLINE MED/20267566
Mizushina Y; Miyazaki S; Ohta K; Hirota M; Sakaguchi K; Department of Applied Biological Science, Faculty of Science and; Technology, Science University of Tokyo, 2641 Yamazaki, Noda,; Chiba, Japan.


Abstract: Novel anti-inflammatory compounds, terpeno-benzoic acids, were found from the plant, Myrsine seguinii. The strongest of these anti-inflammatory agents, 3-geranyl-4-hydroxy-5-(3'-methyl-2'-butenyl) benzoic acid (compound 1), showed an inhibitory effect against enzymes involved in replication, such as calf DNA polymerase alpha (pol. alpha), rat DNA polymerase beta (pol. beta) and one of the beta family polymerases, calf thymus terminal deoxynucleotidyl transferase (TdT). The minimum inhibitory concentration (MIC) and IC50 values were 82 and 22 microM for pol. alpha, 86 and 11 microM for pol. beta, 140 and 46 microM for TdT, respectively. However, compound 1 did not influence the activities of plant DNA polymerases, human immunodeficiency virus type-1 reverse transcriptase, any of the prokaryotic DNA polymerases or DNA and RNA metabolic enzymes tested. Dose-dependent relationships were observed between the anti-inflammatory activities and the DNA polymerase-inhibitory activities of the four derivatives. The carboxylic acid moiety in the benzoic acid of the compounds appeared to be related to the inhibitory effects. The mode of action of the terpeno-benzoic acids against the polymerases and their relationships to the anti-inflammatory activity are discussed.
Keywords: JOURNAL ARTICLE Animal Anti-Inflammatory Agents, Non-Steroidal/ISOLATION & PURIF/ *PHARMACOLOGY Benzoic Acids/ISOLATION & PURIF/*PHARMACOLOGY Cattle Dose-Response Relationship, Drug DNA-Directed DNA Polymerase/*ANTAGONISTS & INHIB Enzyme Inhibitors/ISOLATION & PURIF/PHARMACOLOGY Molecular Structure Plant Extracts/CHEMISTRY Support, Non-U.S. Gov't Terpenes/ISOLATION & PURIF/*PHARMACOLOGY

KWDjournalarticleanimalanti-inflammatoryagents,non-steroidal/isolation&purif/KWDpharmacologybenzoicacids/isolation&purif/KWDpharmacologycattledose-responserelationship,drugdna-directeddnapolymerase/KWDantagonists&inhibenzymeinhibitors/isolation&purif/pharmacologymolecularstructureplantextracts/chemistrysupport,non-uKWDsKWDgov'tterpenes/isolation&purif/KWDpharmacology
000930
A0090728


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .